FDA Approves Third Ustekinumab Biosimilar ...Middle East

Medscape - News
The biosimilar is approved for all indications of the reference medication, Stelara, and will launch in February 2025. Medscape Medical News

Hence then, the article about fda approves third ustekinumab biosimilar was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Third Ustekinumab Biosimilar )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News